Expression of a functional Fas death receptor by human foetal motoneurons

Neuroscience

Volumn 119, Issue 2, 2003, Pages 377-385

  Lautrette, C ^a   Giraud, S ^a   Vermot Desroches, C ^c   Preud'Homme, J L ^b   Jauberteau, M O ^a  

^a LIMOGES UNIVERSITY HOSPITAL   (France)

^b POITIERS UNIVERSITY HOSPITAL   (France)

^c Diaclone   (France)

Author keywords

Apoptosis; Caspase 8; CD95; Fas ligand; Neurons

Indexed keywords

ACETYLCHOLINESTERASE; CASPASE 8; MONOCLONAL ANTIBODY; TRANSFERASE;

APOPTOSIS; ARTICLE; ASTROCYTE; BRAIN CELL; CELL DEATH; CELL SUBPOPULATION; CELL TYPE; CONTROLLED STUDY; FETUS; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOFLUORESCENCE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MOTONEURON; NICK END LABELING; PRIORITY JOURNAL; PROTEIN EXPRESSION; SPINAL CORD; SURFACE PROPERTY;

EID: 0038400971     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00034-4     Document Type: Article

References (56)

1. Bär P.R. Motor neuron disease in vitro the use of cultured motor neurons to study amyotrophic lateral sclerosis . Eur J Pharmacol. 405:2000;285-295.
2. Becher B, D'Souza SD, Troutt AB, Antel JP (1998) Fas expression on human foetal astrocytes without susceptibility to fas-mediated cytotoxicity. Neuroscience 627-634.
3. Campbell M.J., Morrison J.H. Monoclonal antibody to neurofilament protein (SMI-32) labels a subpopulation of pyramidal neurons in the human and monkey neocortex. J Comp Neurol. 282:1989;191-205.
4. Carriedo S.G., Yin H.Z., Lamberta R., Weiss J.H. In vitro kainate injury to large, SMI-32 (+) spinal neurons is Ca2+ dependent. Neuroreport. 6:1995;945-948.
5. Cheema Z.F., Wade S.B., Sata M., Walsh K., Sohrabji F., Miranda R.C. Fas/Apo [apoptosis]-1 and associated proteins in the differentiating cerebral cortex induction of caspase-dependent cell death and activation of NF-kappaB . J Neurosci. 19:1999;1754-1770.
6. Choi C., Park J.Y., Lee J., Lim J.H., Shin E.C., Ahn Y.S., Kim C.H., Kim S.J., Kim J.D., Choi I.S., Choi I.H. Fas ligand and Fas are expressed constitutively in human astrocytes and the expression increases with IL-1, IL-6, TNF-alpha, or IFN-gamma. J Immunol. 162:1999;1889-1895.
7. Ciusani E., Gelati M., Frigerio S., Pollo B., Massa G., Sacerdote P., Panerai A.E., Salmaggi A. Modulation of experimental allergic encephalomyelitis in Lewis rats by administration of a peptide of fas ligand. J Autoimmun. 17:2001;273-280.
8. de la Monte S.M., Sohn Y.K., Wands J.R. Correlates of p53- and Fas (CD95)-mediated apoptosis in Alzheimer's disease. J Neurol Sci. 152:1997;73-83.
9. Deigner H.P., Haberkorn U., Kinscherf R. Apoptosis modulators in the therapy of neurodegenerative diseases. Expert Opin Invest Drugs. 9:2000;747-764.
10. Detrait E., Lhoest J.B., Knoops B., Bertrand P., van den Bosch de Aguilar P. Orientation of cell adhesion and growth on patterned heterogeneous polystyrene surface. J Neurosci Methods. 84:1998;193-204.
11. D'Souza S.D., Bonetti B., Balasingam V., Cashman N.R., Barker P.A., Troutt A.B., Raine C.S., Antel J.P. Multiple sclerosis Fas signaling in oligodendrocyte cell death . J Exp Med. 184:1996;2361-2370.
12. Ferrari D., Stepczynska A., los M., Wesselborg S., Schulze-Osthoff K. Differential regulation and ATP requirement for caspase-8 and caspase-3 activation during CD95- and anticancer drug-induced apoptosis. J Exp Med. 188:1998;979-984.
13. Ferrer I., Puig B., Krupinsk J., Carmona M., Blanco R. Fas and Fas ligand expression in Alzheimer's disease. Acta Neuropathol. 102:2001;121-131.
14. Ferri R.T., Levitt P. Regulation of regional differences in the differentiation of cerebral cortical neurons by EGF family-matrix interactions. Development. 121:1995;1151-1160.
15. Franklin J.L., Johnson E.M.J. Suppression of programmed neuronal death by sustained elevation of cytoplasmique calcium. Trend Neurosci. 15:1992;501-508.
16. Gai W.P., Vickers J.C., Blumbergs P.C., Blessing W.W. Loss of non-phosphorylated neurofilament immunoreactivity, with preservation of tyrosine hydroxylase, in surviving substantia nigra neurons in Parkinson's disease. J Neurol Neurosurg Psychiatry. 57:1994;1039-1046.
17. Gomez C., Reiriz J., Pique M., Gil J., Ferrer I., Ambrosio S. Low concentrations of 1-methyl-4-phenylpyridinium ion induce caspase-mediated apoptosis in human SH-SY5Y neuroblastoma cells. J Neurosci Res. 63:2001;421-428.
18. Green D.R. Activation-induced apoptosis in lymphocytes. Curr Opin Immunol. 6:1994;476-487.
19. Honig L.S., Rosenberg R.N. Apoptosis and neurologic disease. Am J Med. 108:2000;317-330.
20. Irmler M., Thome M., Hahne M., Schneider P., Hofmann K., Steiner V., Bodmer J.L., Schroter M., Burns K., Mattmann C., Rimoldi D., French L.E., Tschopp J. Inhibition of death receptor signals by cellular FLIP. Nature. 388:1997;190-195.
21. Jauberteau M.O., Brindel I., Baumann N., Preud'homme J.L. Reactivity of a human monoclonal anti-GM1 and anti-GD1b IgM antibody with human neurons in cultures. J Neuroimmunol. 48:1993;53-57.
22. Jellinger K.A. Cell death mechanisms in Parkinson's disease. J Neural Transm. 107:2000;1-29.
23. Kataoka T., Budd R.C., Holler N., Thome M., Martinon F., Irmler M., Burns K., Hahne M., Kennedy N., Kovacsovics M., Tschopp J. The caspase-8 inhibitor FLIP promotes activation of NF-kappaB and Erk signaling pathways. Curr Biol. 10:2000;640-648.
24. Kennedy N.J., Kataoka T., Tschopp J., Budd R.C. Caspase activation is required for T cell proliferation. J Exp Med. 190:1999;1891-1896.
25. Kondratyev A.D., Zotova E.E., Loginov B.V., Tsirenina M.L., Melnik E.I., Severin E.S. Production and immunohistochemical characterization of primary cultures of human embryo brain cells. Neuroscience. 32:1989;261-268.
26. Lee S.J., Zhou T., Choi C., Wang Z., Benveniste E.N. Differential regulation and function of Fas expression on glial cells. J Immunol. 164:2000;1277-1285.
27. Lochter A., Taylor J., Braunewell K.H., Holm J., Schachner M. Control of neuronal morphology in vitro interplay between adhesive substrate forces and molecular instruction . J Neurosci Res. 42:1995;145-158.
28. Manolov S., Davidoff M. Acetylcholinesterase activity, choline acetyltransferase and GABA immunoreactivity in the ventral horn of the spinal cord of rats during chromatolysis. Rev Neurol. 145:1989;55-59.
29. Martin-Villalba A., Hahne M., Kleber S., Vogel J., Falk W., Schenkel J., Krammer P.H. Therapeutic neutralization of CD95-ligand and TNF attenuates brain damage in stroke. Cell Death Differ. 8:2001;679-686.
30. Matsuyama T., Hata R., Yamamoto Y., Tagaya M., Akita H., Uno H., Wanaka A., Furuyama J., Sugita M. Localization of Fas antigen mRNA induced in postischemic murine forebrain by in situ hybridization. Brain Res Mol Brain Res. 34:1995;166-172.
31. Meroni L., Varchetta S., Milazzo L., Rusconi S., Galli M. CD95 workshop workshop anti-Fas monoclonal antibodies reactivity and induced apoptosis on peripheral blood lymphocytes . Kishimoto T. Leucocyte typing VI white cell differentiation antigens . 1996;809-810 Garland Publishing, Inc, New York.
32. Mesulam M., Geula C. Differential distribution of a neurofilament protein epitope in acetylcholinesterase-rich neurons of human cerebral cortex. Brain Res. 544:1991;169-173.
33. Mesulam M.M., Mufson E.J., Levey A.I., Wainer B.H. Atlas of cholinergic neurons in the forebrain and upper brainstem of the macaque based on monoclonal choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Neuroscience. 12:1984;669-686.
34. Michel P.P., Ruberg M., Agid Y. Rescue of mesencephalic dopamine neurons by anticancer drug cytosine arabinoside. J Neurochem. 69:1997;1499-1507.
35. Mizukawa K., McGeer P.L., Tago H., Peng J.H., McGeer E.G., Kimura H. The cholinergic system of the human hindbrain studied by choline acetyltransferase immunohistochemistry and acetylcholinesterase histochemistry. Brain Res. 379:1986;39-55.
36. Morishima Y., Gotoh Y., Zieg J., Barrett T., Takano H., Flavell R., Davis R.J., Shirasaki Y., Greenberg M.E. Beta-amyloid induces neuronal apoptosis via a mechanism that involves the c-Jun N-terminal kinase pathway and the induction of Fas ligand. J Neurosci. 21:2001;7551-7560.
37. Nagata S. Apoptosis mediated by the Fas system. Prog Mol Subcell Biol. 16:1996;87-103.
38. Newton K., Kurts C., Harris A.W., Strasser A. Effects of a dominant interfering mutant of FADD on signal transduction in activated T cells. Curr Biol. 11:2001;273-276.
39. Nagy J.I., Yamamoto T., Jordan L.M. Evidence for the cholinergic nature of C-terminals associated with subsurface cisterns in alpha-motoneurons of rat. Synapse. 15:1993;17-32.
40. Oppenheim R.W. Cell death during development of the nervous system. Annu Rev Neurosci. 14:2000;453-501.
41. Orlinick J.R., Vaishnaw A., Elkon K.B., Chao M.V. Requirement of cystein-rich repeats of the Fas receptor for binding by the Fas ligand. J Biol Chem. 272:1997;28889-28894.
42. Park C., Sakamaki K., Tachibana O., Yamashima T., Yamashita J., Yonehara S. Expression of fas antigen in the normal mouse brain. Biochem Biophys Res Commun. 252:1998;623-628.
43. Pouly S., Becher B., Blain M., Antel J.P. Interferon-gamma modulates human oligodendrocyte susceptibility to Fas-mediated apoptosis. J Neuropathol Exp Neurol. 4:2000;280-286.
44. Raoul C., Estevez A.G., Nishimune H., Cleveland D.W., deLapeyriere O., Henderson C.E., Haase G., Pettmann B. Motoneuron death triggered by a specific pathway downstream of Fas potentiation by ALS-linked SOD1 mutations . Neuron. 35:2002;1067-1083.
45. Raoul C., Henderson C.E., Pettmann B. Programmed cell death of embryonic motoneurons triggered through the Fas death receptor. J Cell Biol. 147:1999;1049-1062.
46. Rensing-Ehl A., Malipiero U., Irmler M., Tschopp J., Constam D., Fontana A. Neurons induced to express major histocompatibility complex class I antigen are killed via the perforin and not the Fas (APO-1/CD95) pathway. Eur J Immunol. 9:1996;2271-2274.
47. Robertson M.J., Ritz J., Wang D. CD 95 workshop: characterization of CD95 monoclonal antibodies epitope specificities and functional effects . Kishimoto T. Leucocyte typing VI white cell differentiation antigens . 1996;812-814 Garland Publishing, Inc, New York.
48. Sakurai M., Hayashi T., Abe K., Sadahiro M., Tabayashi K. Delayed selective motor neuron death and fas antigen induction after spinal cord ischemia in rabbits. Brain Res. 797:1998;23-28.
49. Savettieri G., Mazzola G.A., Rodriguez Sanchez M.B., Caruso G., Di Liegro I., Cestelli A. Modulation of synapsin I gene expression in rat cortical neurons by extracellular matrix. Cell Mol Neurobiol. 18:1998;369-378.
50. Sharma K., Wang R.X., Zhang L.Y., Yin D.L., Luo X.Y., Solomon J.C., Jiang R.F., Markos K., Davidson W., Scott D.W., Shi Y.F. Death the Fas way regulation and pathophysiology of CD95 and its ligand . Pharmacol Therapeutics. 88:2000;333-347.
51. Tsang Y.M., Chiong F., Kuznetsov D., Kasarskis E., Geula C. Motor neurons are rich in non-phosphorylated neurofilaments cross-species comparison and alterations in ALS . Brain Res. 861:2000;45-58.
52. Varfolomeev E.E., Schuchmann M., Luria V., Chiannilkulchai N., Beckmann J.S., Mett I.L., Rebrikov D., Brodianski V.M., Kemper O.C., Kollet O., Lapidot T., Soffer D., Sobe T., Avraham K.B., Goncharov T., Holtmann H., Lonai P., Wallach D. Targeted disruption of the mouse Caspase-8 gene ablates cell death induction by the TNF receptors, Fas/Apo1, and DR3 and is lethal prenatally. Immunity. 2:1998;267-276.
53. Vermot-Desroches C., Cattin M.H., Wijdenes J. CD95 workshop different monoclonal antibody valency required to induce apoptosis in SKW6.4 cells . Kishimoto T. Leucocyte typing VI white cell differentiation antigens . 1996;806-808 Garland Publishing, Inc, New York.
54. Wujek J.R., Akeson R.A. Extracellular matrix derived from astrocytes stimulates neuritic outgrowth from PC12 cells in vitro. Brain Res. 431:1987;87-97.
55. Wujek J.R., Haleem-Smith H., Yamada Y., Lipsky R., Lan Y.T., Freese E. Evidence that the B2 chain of laminin is responsible for the neurite outgrowth-promoting activity of astrocyte extracellular matrix. Brain Res Dev Brain Res. 55:1990;237-247.
56. Yi F.H., Lautrette C., Vermot-Desroches C., Bordessoule D., Couratier P., Wijdenes J., Preud'homme J.L., Jauberteau M.O. In vitro induction of neuronal apoptosis by anti-Fas antibody-containing sera from amyotrophic lateral sclerosis patients. J Neuroimmunol. 109:2000;211-220.